Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sheena L. Dupuy"'
Autor:
Stephen L. Hauser, Carlo Asteggiano, Fawad Yousuf, Rohit Bakshi, Tristan Gundel, Amber Alexander, Howard L. Weiner, Brian C. Healy, Fariha Khalid, Sheena L. Dupuy, Roland G. Henry, Gina Kirkish
Publikováno v:
J Neuroimaging
Background and purpose Brain MRI-derived lesions and atrophy are related to multiple sclerosis (MS) disability. In the Serially Unified Multicenter MS Investigation (SUMMIT), from Brigham and Women's Hospital (BWH) and University of California, San F
Autor:
Sheena L. Dupuy, Rohit Bakshi, Renxin Chu, Tanuja Chitnis, Fariha Khalid, Maria K. Houtchens, Brian C. Healy
Publikováno v:
Journal of the Neurological Sciences. 392:94-99
Objective To assess the change in cerebral lesions and atrophy associated with pregnancy in patients with multiple sclerosis (MS). Background Multiple sclerosis often affects women of reproductive age. Disease stabilization typically occurs during pr
Autor:
Tanuja Chitnis, Fariha Khalid, Brian C. Healy, Fawad Yousuf, Rohit Bakshi, Subhash Tummala, Renxin Chu, Shahamat Tauhid, Howard L. Weiner, Sheena L. Dupuy, Gloria Kim
Publikováno v:
Journal of the Neurological Sciences. 383:221-229
Cerebral gray matter (GM) atrophy has clinical relevance in multiple sclerosis (MS). Fingolimod has known efficacy on clinical and conventional MRI findings in MS; the effect on GM is unknown.To explore fingolimod's treatment effect on cerebral GM at
Autor:
Shahamat Tauhid, Alicia S. Chua, Sheena L. Dupuy, Muhammad Taimur Malik, Tanuja Chitnis, Howard L. Weiner, Rohit Bakshi, Camilo Diaz-Cruz, Brian C. Healy, Vinit V. Oommen
Publikováno v:
Journal of Neuroimaging
BACKGROUND Brain lesions converting to chronic T1 hypointensities (“chronic black holes” [CBH]), indicate severe tissue destruction (axonal loss and irreversible demyelination) in multiple sclerosis (MS). Two mechanisms by which fingolimod could
Autor:
Sheena L. Dupuy, Shahamat Tauhid, Gloria Kim, Renxin Chu, Shelley Hurwitz, Rohit Bakshi, Subhash Tummala
Publikováno v:
European Journal of Radiology. 84(8):1564-1568
ObjectiveCompare T1 spin-echo (T1SE) and T1 gradient-echo (T1GE) sequences in detecting hypointense brain lesions in multiple sclerosis (MS).BackgroundChronic hypointense lesions on T1SE MRI scans are a surrogate of severe demyelination and axonal lo
Autor:
Brian C. Healy, Ashish Arora, Mohit Neema, Bonnie I. Glanz, Rohit Bakshi, Ralph H.B. Benedict, Matthew J. Bruha, Nikila Saravanan, Sheena L. Dupuy, Shahamat Tauhid, Elisa Dell'Oglio, Antonia Ceccarelli, Alexander V. Vartanian
Publikováno v:
Journal of Neuroimaging. 25:191-199
PURPOSE We tested the validity of a freely available segmentation pipeline to measure compartmental brain volumes from 3T MRI in patients with multiple sclerosis (MS). Our primary focus was methodological to explore the effect of segmentation correct
Autor:
Brian C. Healy, Howard L. Weiner, Gloria Kim, Sheena L. Dupuy, Keren Regev, Rohit Bakshi, Subhash Tummala, Fariha Khalid, Camilo Diaz-Cruz, Radhika Raheja, Tanuja Chitnis, Roopali Gandhi, Maria Antonietta Mazzola, Renxin Chu, Shahamat Tauhid, Anu Paul, Pia Kivisäkk, Felipe von Glehn
Publikováno v:
JAMA neurology. 74(3)
Importance MicroRNAs (miRNAs) are promising multiple sclerosis (MS) biomarkers. Establishing the association between miRNAs and magnetic resonance imaging (MRI) measures of disease severity will help define their significance and potential impact. Ob
Autor:
Sheena L. Dupuy, Rohit Bakshi, Brian C. Healy, Shahamat Tauhid, Sonya Bakshi, Fariha Khalid, Mohit Neema
Publikováno v:
BMC Medical Imaging
Background Spinal cord atrophy occurs early in multiple sclerosis (MS) and impacts disability. The therapeutic effect of interferon beta-1a (IFNβ-1a) on spinal cord atrophy in patients with relapsing-remitting (RR) MS has not been explored. Methods
Publikováno v:
Neurology and Therapy
Introduction The objective of this pilot study was to compare cerebral gray matter (GM) atrophy over 1 year in patients starting dimethyl fumarate (DMF) for multiple sclerosis (MS) to that of patients on no disease-modifying treatment (noDMT). DMF is
Autor:
Elisa, Dell'Oglio, Antonia, Ceccarelli, Bonnie I, Glanz, Brian C, Healy, Shahamat, Tauhid, Ashish, Arora, Nikila, Saravanan, Matthew J, Bruha, Alexander V, Vartanian, Sheena L, Dupuy, Ralph H B, Benedict, Rohit, Bakshi, Mohit, Neema
Publikováno v:
Journal of Neuroimaging
Purpose We tested the validity of a freely available segmentation pipeline to measure compartmental brain volumes from 3T MRI in patients with multiple sclerosis (MS). Our primary focus was methodological to explore the effect of segmentation correct